2025-02-012026-01-312026-01-31false13139330MAY HEALTH GLOBAL LIMITED2026-10-1947910falseiso4217:GBPxbrli:pure131393302025-01-31131393302026-01-31131393302025-02-012026-01-31131393302024-01-31131393302025-01-31131393302024-02-012025-01-3113139330bus:SmallEntities2025-02-012026-01-3113139330bus:AuditExempt-NoAccountantsReport2025-02-012026-01-3113139330bus:FullAccounts2025-02-012026-01-3113139330bus:PrivateLimitedCompanyLtd2025-02-012026-01-3113139330core:WithinOneYear2026-01-3113139330core:AfterOneYear2026-01-3113139330core:WithinOneYear2025-01-3113139330core:AfterOneYear2025-01-311313933012025-02-012026-01-3113139330core:ShareCapital2026-01-3113139330core:SharePremium2026-01-3113139330core:RevaluationReserve2026-01-3113139330core:OtherReservesSubtotal2026-01-3113139330core:RetainedEarningsAccumulatedLosses2026-01-3113139330core:ShareCapital2025-01-3113139330core:SharePremium2025-01-3113139330core:RevaluationReserve2025-01-3113139330core:OtherReservesSubtotal2025-01-3113139330core:RetainedEarningsAccumulatedLosses2025-01-3113139330core:LandBuildings2026-01-3113139330core:PlantMachinery2026-01-3113139330core:Vehicles2026-01-3113139330core:FurnitureFittings2026-01-3113139330core:OfficeEquipment2026-01-3113139330core:NetGoodwill2026-01-3113139330core:IntangibleAssetsOtherThanGoodwill2026-01-3113139330core:ListedExchangeTraded2026-01-3113139330core:UnlistedNon-exchangeTraded2026-01-3113139330core:LandBuildings2025-01-3113139330core:PlantMachinery2025-01-3113139330core:Vehicles2025-01-3113139330core:FurnitureFittings2025-01-3113139330core:OfficeEquipment2025-01-3113139330core:NetGoodwill2025-01-3113139330core:IntangibleAssetsOtherThanGoodwill2025-01-3113139330core:ListedExchangeTraded2025-01-3113139330core:UnlistedNon-exchangeTraded2025-01-3113139330core:LandBuildings2025-02-012026-01-3113139330core:PlantMachinery2025-02-012026-01-3113139330core:Vehicles2025-02-012026-01-3113139330core:FurnitureFittings2025-02-012026-01-3113139330core:OfficeEquipment2025-02-012026-01-3113139330core:NetGoodwill2025-02-012026-01-3113139330core:IntangibleAssetsOtherThanGoodwill2025-02-012026-01-3113139330core:ListedExchangeTraded2025-02-012026-01-3113139330core:UnlistedNon-exchangeTraded2025-02-012026-01-3113139330core:MoreThanFiveYears2025-02-012026-01-3113139330core:Non-currentFinancialInstruments2026-01-3113139330core:Non-currentFinancialInstruments2025-01-3113139330dpl:CostSales2025-02-012026-01-3113139330dpl:DistributionCosts2025-02-012026-01-3113139330core:LandBuildings2025-02-012026-01-3113139330core:PlantMachinery2025-02-012026-01-3113139330core:Vehicles2025-02-012026-01-3113139330core:FurnitureFittings2025-02-012026-01-3113139330core:OfficeEquipment2025-02-012026-01-3113139330dpl:AdministrativeExpenses2025-02-012026-01-3113139330core:NetGoodwill2025-02-012026-01-3113139330core:IntangibleAssetsOtherThanGoodwill2025-02-012026-01-3113139330dpl:GroupUndertakings2025-02-012026-01-3113139330dpl:ParticipatingInterests2025-02-012026-01-3113139330dpl:GroupUndertakingscore:ListedExchangeTraded2025-02-012026-01-3113139330core:ListedExchangeTraded2025-02-012026-01-3113139330dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-02-012026-01-3113139330core:UnlistedNon-exchangeTraded2025-02-012026-01-3113139330dpl:CostSales2024-02-012025-01-3113139330dpl:DistributionCosts2024-02-012025-01-3113139330core:LandBuildings2024-02-012025-01-3113139330core:PlantMachinery2024-02-012025-01-3113139330core:Vehicles2024-02-012025-01-3113139330core:FurnitureFittings2024-02-012025-01-3113139330core:OfficeEquipment2024-02-012025-01-3113139330dpl:AdministrativeExpenses2024-02-012025-01-3113139330core:NetGoodwill2024-02-012025-01-3113139330core:IntangibleAssetsOtherThanGoodwill2024-02-012025-01-3113139330dpl:GroupUndertakings2024-02-012025-01-3113139330dpl:ParticipatingInterests2024-02-012025-01-3113139330dpl:GroupUndertakingscore:ListedExchangeTraded2024-02-012025-01-3113139330core:ListedExchangeTraded2024-02-012025-01-3113139330dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-02-012025-01-3113139330core:UnlistedNon-exchangeTraded2024-02-012025-01-3113139330core:NetGoodwill2026-01-3113139330core:IntangibleAssetsOtherThanGoodwill2026-01-3113139330core:LandBuildings2026-01-3113139330core:PlantMachinery2026-01-3113139330core:Vehicles2026-01-3113139330core:FurnitureFittings2026-01-3113139330core:OfficeEquipment2026-01-3113139330core:AfterOneYear2026-01-3113139330core:WithinOneYear2026-01-3113139330core:ListedExchangeTraded2026-01-3113139330core:UnlistedNon-exchangeTraded2026-01-3113139330core:ShareCapital2026-01-3113139330core:SharePremium2026-01-3113139330core:RevaluationReserve2026-01-3113139330core:OtherReservesSubtotal2026-01-3113139330core:RetainedEarningsAccumulatedLosses2026-01-3113139330core:NetGoodwill2025-01-3113139330core:IntangibleAssetsOtherThanGoodwill2025-01-3113139330core:LandBuildings2025-01-3113139330core:PlantMachinery2025-01-3113139330core:Vehicles2025-01-3113139330core:FurnitureFittings2025-01-3113139330core:OfficeEquipment2025-01-3113139330core:AfterOneYear2025-01-3113139330core:WithinOneYear2025-01-3113139330core:ListedExchangeTraded2025-01-3113139330core:UnlistedNon-exchangeTraded2025-01-3113139330core:ShareCapital2025-01-3113139330core:SharePremium2025-01-3113139330core:RevaluationReserve2025-01-3113139330core:OtherReservesSubtotal2025-01-3113139330core:RetainedEarningsAccumulatedLosses2025-01-3113139330core:NetGoodwill2024-01-3113139330core:IntangibleAssetsOtherThanGoodwill2024-01-3113139330core:LandBuildings2024-01-3113139330core:PlantMachinery2024-01-3113139330core:Vehicles2024-01-3113139330core:FurnitureFittings2024-01-3113139330core:OfficeEquipment2024-01-3113139330core:AfterOneYear2024-01-3113139330core:WithinOneYear2024-01-3113139330core:ListedExchangeTraded2024-01-3113139330core:UnlistedNon-exchangeTraded2024-01-3113139330core:ShareCapital2024-01-3113139330core:SharePremium2024-01-3113139330core:RevaluationReserve2024-01-3113139330core:OtherReservesSubtotal2024-01-3113139330core:RetainedEarningsAccumulatedLosses2024-01-3113139330core:AfterOneYear2025-02-012026-01-3113139330core:WithinOneYear2025-02-012026-01-3113139330core:Non-currentFinancialInstrumentscore:CostValuation2025-02-012026-01-3113139330core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-02-012026-01-3113139330core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-02-012026-01-3113139330core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-02-012026-01-3113139330core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-02-012026-01-3113139330core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-02-012026-01-3113139330core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-02-012026-01-3113139330core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-02-012026-01-3113139330core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-02-012026-01-3113139330core:Non-currentFinancialInstrumentscore:CostValuation2026-01-3113139330core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-01-3113139330core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-01-3113139330core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-01-3113139330core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-01-3113139330core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-01-3113139330core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-01-3113139330core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-01-3113139330core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-01-3113139330core:Non-currentFinancialInstrumentscore:CostValuation2025-01-3113139330core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-3113139330core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-3113139330core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-3113139330core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-3113139330core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-3113139330core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-3113139330core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-3113139330core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-3113139330bus:Director12025-02-012026-01-31

MAY HEALTH GLOBAL LIMITED

(formerly SAINT’S CHOICE LIMITED)

Registered Number
13139330
(England and Wales)

Unaudited Financial Statements for the Year ended
31 January 2026

MAY HEALTH GLOBAL LIMITED
Company Information
for the year from 1 February 2025 to 31 January 2026

Director

SHI, Lijing

Registered Address

Unit 1e, Bromsgrove House
88 Bromsgrove Street
Birmingham
B5 6AJ

Registered Number

13139330 (England and Wales)
MAY HEALTH GLOBAL LIMITED
Statement of Financial Position
31 January 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Intangible assets3339507
339507
Current assets
Stocks43,796-
Debtors51,33247,101
Cash at bank and on hand164,733132,754
169,861179,855
Creditors amounts falling due within one year6(3,290)(8,389)
Net current assets (liabilities)166,571171,466
Total assets less current liabilities166,910171,973
Creditors amounts falling due after one year7(55,470)(71,135)
Net assets111,440100,838
Capital and reserves
Called up share capital100100
Profit and loss account111,340100,738
Shareholders' funds111,440100,838
The financial statements were approved and authorised for issue by the Director on 19 October 2026, and are signed on its behalf by:
SHI, Lijing
Director
Registered Company No. 13139330
MAY HEALTH GLOBAL LIMITED
Notes to the Financial Statements
for the year ended 31 January 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A, as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

20262025
Average number of employees during the year11
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 February 25840840
At 31 January 26840840
Amortisation and impairment
At 01 February 25333333
Charge for year168168
At 31 January 26501501
Net book value
At 31 January 26339339
At 31 January 25507507
4.Stocks

2026

2025

££
Raw materials and consumables3,796-
Total3,796-
5.Debtors: amounts due within one year

2026

2025

££
Trade debtors / trade receivables13246,748
Other debtors1,200353
Total1,33247,101
6.Creditors: amounts due within one year

2026

2025

££
Trade creditors / trade payables2,55434
Taxation and social security736-
Accrued liabilities and deferred income-8,355
Total3,2908,389
7.Creditors: amounts due after one year

2026

2025

££
Amounts owed to related parties55,47055,135
Other creditors-16,000
Total55,47071,135